Efficacy and Safety of T1225 1.5% Versus Tobramycin 0.3 % in the Treatment of Purulent Bacterial Conjunctivitis

Clinical trial NCT00357773 · COMPLETED

Trial details

NCT number: NCT00357773
Sponsor: Laboratoires Thea
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Conjunctivitis, Bacterial

Start date: 2004-05-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.